SPRING CONFERENCE: The Global Challenge of Multi-drug Resistant Gram Negative Bacteria Infections

Transcription

1 The Global Challenge of Multi-drug Resistant Gram Negative Bacteria Infections Tuesday 14 March 2017, Queen Elizabeth II Conference Centre, London In collaboration with the Healthcare Infection Society PROGRAMME CPD ACCREDITED

2 02 Welcome Welcome to the BSAC Spring Conference 2017, held in collaboration with the Healthcare Infection Society. Multi-drug resistant gram negative bacterial infections have become prevalent across the globe. Their proliferation is fueled and encouraged by increased use of broad spectrum agents, and identification of successful treatment regimens have been challenged in recent years by the lack of new antibiotics available to treat them. Outbreaks of MDR infections adversely impact of patients quality of life, increase length of hospital stay and place considerable financial burdens on healthcare systems and services. This conference will, through state of the art lectures, free papers and presentation of the latest evidence, offer delegates the opportunity to learn about the global and UK burden of MDR infections, examine current and new treatments, examine how existing and new diagnostics can support their detection and how prevention and stewardship can reduce prevalence and improve outcomes. We look forward to welcoming you!

3 03 Programme 0830 REGISTRATION AND COFFEE 0905 Welcome Professor Dilip Nathwani OBE, President, BSAC SESSION ONE: Clinical Epidemiology of GNB Infections Chair: Professor Dilip Nathwani OBE, President, BSAC 0910 The current global and UK epidemiology of GNB infections Professor Timothy Walsh, Professor of Medical Microbiology and Antibiotic Resistance, 0935 Burden and current global management on GNB infections: Lessons from a global PPS Dr Ann Versporten, Global PPS Coordination Centre, University of Antwerp, Antwerp 0955 Clinical presentations and impact of GNB infections in the UK Dr Gavin Barlow, Infectious Diseases Consultant, Hull & East Yorkshire Hospitals NHS Trust 1015 Hospital antibiotic prescribing to minimise AMR - the Antibiotic Reduction Kit (ARK-Hospital) Programme Professor Martin Llewelyn, Reader in Infectious Diseases, Brighton and Sussex Medical School 1030 COFFEE AND NETWORKING SESSION TWO: Current and new treatments of MDRGNB infections Chair: Professor Timothy Walsh, Professor of Medical Microbiology and Antibiotic Resistance, Cardiff University 1100 NDM, ESBL and KPC - the US experience Dr Lillian Abbo, Chief Infection Prevention & Antimicrobial Stewardship JHS President WIAM Advisory Board UMMSM, Jackson Health System, University of Miami, United States 1125 UK Guidelines for GNB infections Professor Peter Hawkey, PHE Lead Public Health Microbiologist, Heart of England NHS Foundation Trust, Birmingham UK 1150 Optimising PK/PD for treatment of GNB Dr Frederico Pea, Institute of Clinical Pharmacology and Toxicology, University Teaching 1215 AGM & LUNCH

4 04 SESSION THREE: Supported Symposium 1345 Details to be confirmed SESSION FOUR: Free papers Chair: Dr Emma Boldock, Microbiology Registrar & NIHR Academic Clinical Lecturer, Sheffield 1415 A randomised controlled trial evaluating the TARGET (Treat Antibiotics Responsibly, Guidance, Education, Tools) Antibiotics toolkit Miss Leah Jones, Trainee Health Psychologist & Research Assistant, Public Health England 1430 Rapid phenotypic susceptibility testing of bacteria: SLIC by name and slick by nature SESSION FIVE: Stewardship, research and prevention Chair: Dr Gavin Barlow, Consultant Physician, Hull & East Yorkshire Hospitals NHS Trust, East Yorkshire 1445 Quality indicators and quantity metrics for responsible antibiotic use, lessons from DRIVE-AB Dr Vera Vlahović-Palčevski, Clinical Pharmacologist, DRIVE-AB & University of Rijeka, Croatia 1505 UK approach to use of metrics and targets for GNB infections Dr Susan Hopkins, Consultant in Infectious Diseases & Microbiology, Royal Free Hospital, NHS Trust, London 1525 GNB infections and stewardship Professor Dilip Nathwani OBE, Consultant Physician and Honorary Professor of Infection, University of Dundee, Dundee UK 1545 Prevention of GNB infections Professor Peter Wilson, Consultant Microbiologist, UCHL Foundation NHS Trust, London 1610 Drug discovery to combat GNB infections: current challenges and possible progress Professor Mike Ferguson, Regius Professor and Associate Dean for Research Strategy, Biologicial Chemistry and Drug Discovery, University of Dundee, Dundee UK 1630 Closing remarks

5 05 Registration form Please complete ALL SECTIONS in BLOCK capitals Title: Surname: First name: Job Title: Department: Institute name & address: Postcode: Tel: PAYMENT DETAILS Payment in Sterling should be made as follows: CHEQUE MADE PAYABLE TO BSAC ENCLOSED PLEASE SEND AN INVOICE - PO NUMBER CHARGE TO CREDIT/DEBIT CARD (please indicate card number, expiry date and security number) MASTERCARD VISA SWITCH EUROCARD SOLO ELECTRON SECURITY NO ISSUE NO switch only CARD NUMBER START DATE CARDHOLDER S NAME CARDHOLDER S HOME ADDRESS EXPIRY DATE REGISTRATION FEES (These fees are inclusive of VAT) (please tick) BSAC/HIS Members (NHS) BSAC/HIS Members (commercial) Non BSAC/HIS Members (NHS) Non BSAC/HIS Members (Commercial) BSAC & HIS Members Trainee Non BSAC/HIS Members Trainee Students CANCELLATION POLICY No refunds will be given for cancellation notified on or after 28 days prior to the event. I authorise the use of my credit card for this purpose Signature Date PLEASE COMPLETE ALL SECTIONS AND SEND TO: Esme Carruthers BSAC, Griffin House, 53 Regent Place, Birmingham, B1 3NJ Tel: +44 (0) ECarruthers@bsac.org.uk From time to time we would like to you with information about BSAC activities which we believe will be of interest to you. This will not involve your details being passed to any third party and you can unsubscribe at any time. If you would like to receive this information please tick the box. Yes, I would be happy to receive information from the BSAC

6 Griffin House 53 Regent Place Birmingham B1 3NJ T: +44 (0)